| 000 | 01851 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516032203.0 | ||
| 264 | 0 | _c20110914 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00016-11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcGee, David J | |
| 245 | 0 | 0 |
_aCholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJun 2011 |
||
| 300 |
_a2897-904 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xphysiology |
| 650 | 0 | 4 |
_aBismuth _xpharmacology |
| 650 | 0 | 4 |
_aCell Wall _xdrug effects |
| 650 | 0 | 4 |
_aCholesterol _xpharmacology |
| 650 | 0 | 4 |
_aDNA Replication _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aFolic Acid _xmetabolism |
| 650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
| 650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
| 650 | 0 | 4 |
_aLipid A _xmetabolism |
| 650 | 0 | 4 |
_aMonomeric GTP-Binding Proteins _xphysiology |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoric Monoester Hydrolases _xphysiology |
| 650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aSalicylates _xpharmacology |
| 650 | 0 | 4 | _aCathelicidins |
| 700 | 1 | _aGeorge, Alika E | |
| 700 | 1 | _aTrainor, Elizabeth A | |
| 700 | 1 | _aHorton, Katherine E | |
| 700 | 1 | _aHildebrandt, Ellen | |
| 700 | 1 | _aTesterman, Traci L | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 55 _gno. 6 _gp. 2897-904 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00016-11 _zAvailable from publisher's website |
| 999 |
_c20732290 _d20732290 |
||